[ Price : $8.95]
CDERs Office of Prescription Drug Promotion says that a Sunovion sales representative made false or misleading statements about La...[ Price : $8.95]
CDERs Office of Prescription Drug Promotion says that a convention display booth for NeurogesX Qutenza failed to communicate risk ...[ Price : $8.95]
Gilead says it is seeking a new indication for Truvada for pre-exposure prophylaxis to prevent HIV-1 infection.[ Price : $8.95]
CDERs Office of Prescription Drug Promotion says an EUSA ProstaScint fact sheet fails to provide important information, overstates...[ Price : $8.95]
FDA tells Corcept Therapeutics that it will not require a Risk Evaluation and Mitigation Strategy program as part of its NDA submi...[ Price : $8.95]
FDA clears a Critical Diagnostics 510(k) for the Presage ST2 Assay for use as an aid in assessing the prognosis of patients diagno...[ Price : $8.95]
CMS delays the deadline for drug, medical device, and biologics manufacturers to report payments of more than $10 they make to doc...[ Price : $8.95]
U.S. senators Chuck Grassley (R-IA), Richard Blumenthal (D-CT) and Herb Kohl (D-WI) introduce the Medical Device Patient Safety Ac...